Assignee
NEOGENE THERAPEUTICS B V
NL·1 granted patent·4 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
5 records- 0136US12492386B2Methods to enrich genetically engineered T cellsNEOGENE THERAPEUTICS B V·Filed 2021·Granted Dec 9, 2025·0 cites·16 claims
- 0236US2022228164A1Engineered antigen presenting cellsNEOGENE THERAPEUTICS B V·Filed 2022·Application pending·0 cites
- 0336US2022195006A1Peptide markers to track genetically engineered cellsNEOGENE THERAPEUTICS B V·Filed 2021·Application pending·0 cites
- 0436US2023372485A1Engineered t cells with reduced tgf-beta receptor signalingNEOGENE THERAPEUTICS B V·Filed 2022·Application pending·0 cites
- 0531US2021040558A1Method to isolate tcr genesNEOGENE THERAPEUTICS B V·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEOGENE THERAPEUTICS B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →